Effects of remifentanil on human heart electrical system: A transesophageal pacing electrophysiological study

Minerva Anestesiologica

Volumn 69, Issue 9, 2003, Pages 673-679

  Fattorini, F ^a,c   Romano, R ^b   Ciccaglioni, A ^a   Pascarella, M A ^a   Rocco, A ^a   Mariani, V ^a   Pietropaoli, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c NONE   (Italy)

Author keywords

Anesthetics, general; Bradycardia; Cardiac pacing, artificial; Heart block; Remifentanil; Sinoatrial node, physiopathology

Indexed keywords

REMIFENTANIL; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ARTICLE; CHRONOTROPISM; DRUG EFFECT; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; NORMAL HUMAN; WENCKEBACH PERIOD; ADULT; ELECTROPHYSIOLOGY; FEMALE; HEART; MALE; MIDDLE AGED; PHYSIOLOGY;

ADULT; ANALGESICS, OPIOID; ELECTROPHYSIOLOGY; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; PIPERIDINES;

EID: 1542751347     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dershwitz M, Randel GL, Rosow CE, Fragen RJ, Connors PM, Librojo ES et al. Initial clinical experience with Remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995;81:619-23.
2. Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR et al. The pharmacokinetics of a new short-acting opioid: remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993;79:881-92.
3. Fellowman PL. Design, synthesis and pharmacological evaluation of ultra-short to long-acting opioid analgesics. J Med Chem 1991;34:2202-8.
4. Glass PS, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short acting opioid: remifentanil (GI87084B). Anesth Analg 1993;77:1031-40.
5. Antognini F, Ricci L, Venditti N, De Angelis C, Quattrini A, Testasecca D. Anaesthesia-analgesia with remifentanil. Instrumental, laboratory and clinical evaluations. Minerva Anestesiol 2000;66:424-8.
6. Cort J, Parsloe M. Simple remifentanil infusions. Anaesthesia 2000;55:90.
7. Elliott P, O'Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK. Severe cardiovascular depression with remifentanil. Anesth Analg 2000;91:58-61.
8. Pitts MC. Pilot study: hemodynamic effects of intravenous remifentanil in patients undergoing elective surgery. Anesthesiology 1992;77:A101.
9. Altermatt FR, Muñoz HR. Asystole with propofol and remifentanil. Br J Anaesth 2000;84:696-7.
10. Desouza G, Lewis MC, Terriet MF. Severe bradycardia after remifentanil. Anesthesiology 1997;87:1019-20.
11. Reid JE, Minikhur RK. Bradycardia after administration of remifentanil. Br J Anaesth 2000;84:422-3.
12. Gallagher JJ, Smith WM, Kerr CR, Kasell J, Cook L, Reiter M et al. Esophageal pacing: a diagnostic and therapeutic tool. Circulation 1982;65:336-11.
13. Romano R, Ciccaglioni A, Fattorini F, Quaglione R, Favaro R, Arcioni R et al. Effects of propofol on the human heart electrical system: 7 transesophageal pacing electrophysiologic study. Acta Anaesthesiol Scand 1994;38:30-2.
14. Sharpe MD, Cuilerier DJ, Lee JK, Basta M, Krahn AD, Klein GJ et al. Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome. Anesthesiology 1999;80:63-70.